DETROIT, Aug. 21, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to report today the results of testing of its proprietary Nanotechnology Immune Stimulant (NIS) which prevents the propagations of infections made by Vibrio Parahaemolyticus, a bacteria that cause disease in cultured shrimp.
Nano Lab's innovative solution is a Nanotech Immune Stimulant (NIS), which modulates the response of the immune system in shrimp. Tests conducted in partnership with CIBNOR, Bioassay Project No 960-0, shows the NIS increases the number of immune cells, and a considerable reduction of the proliferation rate of the bacteria.
Nano Labs and CIBNOR are pleased to report the following first round of results from the commercial pilot program.The NIS was incorporated in the shrimp feed at various concentrations where the shrimps were fed daily at libitum up to 30 days. The daily administration of the NIS ranged in concentrations of 0 μg NIS / gram of feed (for the control tank) up to 500 μg NIS / gram of feed across six (6) treatment tanks. The treatment tanks contained three hundred (300) shrimp per tank and the mortality rate was recorded daily on the total 1,800 shrimp infected with the Parahaemolyticus Vibrio. The percentage of shrimp survival after direct infection was 15% and 20% at 500 ug NIS / gram of feed. Further, the trials showed there is no health risk to the shrimp and the product does not affect shrimp larval development or survival. "The laboratory preliminary numbers show promising results for shrimp at the levels tested and these dosages are effective against Parahaemolyticus Vibrio. The NIS has remarkable antibacterial activity towards the bacteria when it is incorporated in the culture media at concentrations over 10%," states Dr. Victor Castano, Chief Innovations Officer at Nano Labs. "Further tests are required that compare the effectiveness of our nanotech immune stimulant with other products available on the market as a antibacterial cocktail, as Parahaemolyticus Vibrio affects 30% of worldwide shrimp production. We are continuing to develop and test the product with the goal of achieving a 100% survival rate."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV